At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Treatment of Atypical Teratoid/Rhabdoid Tumors (AT/RT) of the Central Nervous System With Surgery, Intensive Chemotherapy, and 3-D Conformal Radiation
In Brief
A Phase 3 clinical trial evaluating 3-Dimensional Conformal Radiation Therapy, Autologous Hematopoietic Stem Cell Transplantation, and 10 other interventions for Childhood Atypical Teratoid/Rhabdoid Tumor. Completed, enrolled 70 participants across 94 sites in 3 countries.
Detailed Summary
This phase III trial studies the side effects of combination chemotherapy, 3-dimensional conformal radiation therapy, and an autologous peripheral blood stem cell transplant, and to see how well they work in treating young patients with atypical teratoid/rhabdoid tumor of the central nervous system. Giving high-dose chemotherapy before an autologous peripheral blood stem cell transplant stops the growth of cancer cells by stopping them from dividing or killing them. Giving colony-stimulating factors, such as G-CSF, helps stem cells move from the bone marrow to the blood so they can be collected and stored. Chemotherapy or radiation therapy is then given to prepare the bone marrow for the stem cell transplant. The stem cells are then returned to the patient to replace the blood-forming cells that were destroyed by the chemotherapy or radiation therapy.
Study Details
Timeline
Interventions
Undergo 3D-CRT
Undergo autologous PBSC rescue
Given IV
Given IV
Given IV
Given IV
Given IV or SC
Correlative studies
Given IV or PO
Given IV
Given IV
Given IV